Leveraging comparative effectiveness research to improve the quality of multidisciplinary care for breast cancer patients

Lane L. Frasier; Caprice C. Greenberg; Heather B. Neuman

doi:10.1007/978-3-319-12553-4_2

Leveraging comparative effectiveness research to improve the quality of multidisciplinary care for breast cancer patients

Lane L. Frasier, Caprice C. Greenberg, Heather B. Neuman

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Breast cancer is the most commonly diagnosed cancer among women. To date, the use of efficacy randomized controlled trials (RCTs) in breast cancer have resulted in dramatic improvements in oncologic outcomes for this disease. However, not every question pertinent to breast cancer is amenable to such efficacy trials. This chapter will discuss some of the unique aspects of breast cancer that make efficacy RCTs challenging and/or impractical, how comparative effectiveness research can be used to address these issues, and identify several key questions which would benefit from ongoing comparative effectiveness research.

Original language	English (US)
Pages (from-to)	15-30
Number of pages	16
Journal	Cancer treatment and research
Volume	164
DOIs	https://doi.org/10.1007/978-3-319-12553-4_2
State	Published - 2015
Externally published	Yes

Keywords

Axillary lymph node dissection
Breast cancer
Breast conserving therapy (BCT)
Comparative effectiveness research
Hormonal therapy
Hormone receptor status
Mastectomy
Sentinel lymph node biopsy

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/978-3-319-12553-4_2

Cite this

@article{3d406226294e4b149e9c379632ab0cdc,

title = "Leveraging comparative effectiveness research to improve the quality of multidisciplinary care for breast cancer patients",

abstract = "Breast cancer is the most commonly diagnosed cancer among women. To date, the use of efficacy randomized controlled trials (RCTs) in breast cancer have resulted in dramatic improvements in oncologic outcomes for this disease. However, not every question pertinent to breast cancer is amenable to such efficacy trials. This chapter will discuss some of the unique aspects of breast cancer that make efficacy RCTs challenging and/or impractical, how comparative effectiveness research can be used to address these issues, and identify several key questions which would benefit from ongoing comparative effectiveness research.",

keywords = "Axillary lymph node dissection, Breast cancer, Breast conserving therapy (BCT), Comparative effectiveness research, Hormonal therapy, Hormone receptor status, Mastectomy, Sentinel lymph node biopsy",

author = "Frasier, {Lane L.} and Greenberg, {Caprice C.} and Neuman, {Heather B.}",

note = "Publisher Copyright: {\textcopyright} Springer International Publishing Switzerland 2015.",

year = "2015",

doi = "10.1007/978-3-319-12553-4_2",

language = "English (US)",

volume = "164",

pages = "15--30",

journal = "Cancer treatment and research",

issn = "0927-3042",

publisher = "Springer Netherlands",

}

TY - JOUR

T1 - Leveraging comparative effectiveness research to improve the quality of multidisciplinary care for breast cancer patients

AU - Frasier, Lane L.

AU - Greenberg, Caprice C.

AU - Neuman, Heather B.

N1 - Publisher Copyright: © Springer International Publishing Switzerland 2015.

PY - 2015

Y1 - 2015

N2 - Breast cancer is the most commonly diagnosed cancer among women. To date, the use of efficacy randomized controlled trials (RCTs) in breast cancer have resulted in dramatic improvements in oncologic outcomes for this disease. However, not every question pertinent to breast cancer is amenable to such efficacy trials. This chapter will discuss some of the unique aspects of breast cancer that make efficacy RCTs challenging and/or impractical, how comparative effectiveness research can be used to address these issues, and identify several key questions which would benefit from ongoing comparative effectiveness research.

AB - Breast cancer is the most commonly diagnosed cancer among women. To date, the use of efficacy randomized controlled trials (RCTs) in breast cancer have resulted in dramatic improvements in oncologic outcomes for this disease. However, not every question pertinent to breast cancer is amenable to such efficacy trials. This chapter will discuss some of the unique aspects of breast cancer that make efficacy RCTs challenging and/or impractical, how comparative effectiveness research can be used to address these issues, and identify several key questions which would benefit from ongoing comparative effectiveness research.

KW - Axillary lymph node dissection

KW - Breast cancer

KW - Breast conserving therapy (BCT)

KW - Comparative effectiveness research

KW - Hormonal therapy

KW - Hormone receptor status

KW - Mastectomy

KW - Sentinel lymph node biopsy

UR - http://www.scopus.com/inward/record.url?scp=84923322916&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923322916&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-12553-4_2

DO - 10.1007/978-3-319-12553-4_2

M3 - Article

C2 - 25677016

AN - SCOPUS:84923322916

SN - 0927-3042

VL - 164

SP - 15

EP - 30

JO - Cancer treatment and research

JF - Cancer treatment and research

ER -

Leveraging comparative effectiveness research to improve the quality of multidisciplinary care for breast cancer patients

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this